Kim Dong Min, Shin Myung Jin, Kim Hyojune, Park Dongjun, Jeon In-Ho, Kholinne Erica, Koh Kyoung Hwan
Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Department of Orthopedic Surgery, St Carolus Hospital, Jakarta, Indonesia.
Orthop J Sports Med. 2020 Mar 5;8(3):2325967120904937. doi: 10.1177/2325967120904937. eCollection 2020 Mar.
The treatment of irreparable rotator cuff tears (IRCTs) is a significant challenge, and various treatment options have emerged. Superior capsular reconstruction (SCR) is a promising procedure for patients with IRCTs.
To investigate the clinical outcomes of SCR and compare allografts with autografts.
Systematic review; Level of evidence, 4.
A search for relevant articles was carried out using the PubMed, Cochrane Library, Embase, Scopus, and Google Scholar databases. We used medical subject heading (MeSH) terms and natural keywords (superior AND (capsule OR capsular) AND reconstruction). Also, we filtered for high-quality articles using the Methodological Index for Non-Randomized Studies (MINORS). We summarized the characteristic data and commonly used outcome measures of each included study and performed a descriptive analysis using an evidence-based tendency concept as proposed by Huisstede et al (2013).
A total of 10 articles (374 shoulders) with a mean follow-up of 27.2 months were selected and analyzed. There were 4 articles on SCR with an autograft, 4 on SCR with an allograft, and 2 on SCR with both an autograft and allograft. For autografts and allografts, respectively, the mean gain in forward elevation (FE) was 48.7° and 33.3°, the visual analog scale for pain score improved by 3.5 and 3.3, the American Shoulder and Elbow Surgeons (ASES) score increased by 47.3 and 31.9, and the acromiohumeral distance increased by 1.2 and 1.8 mm. In addition, the number of graft tears was 16 (10.0%) and 17 (12.9%), the number of other complications was 12 (7.5%) and 6 (3.9%), and the number of reoperations was 5 (3.1%) and 14 (8.2%) for autografts and allografts, respectively.
Both autografts and allografts improved clinical outcomes. Although the graft tear rate appeared similar between the autograft and allograft groups, the autograft group had no cases of conversion to reverse total shoulder arthroplasty. In addition, we found 3 evidence-based tendencies: (1) a tendency for both autografts and allografts to have significantly improved FE and clinical scores, (2) a tendency that autografts improved internal rotation and allografts improved abduction, and (3) a weak tendency that autografts improved abduction and allografts improved internal and external rotation. Although it was not possible to compare the groups statistically, the differences in ASES scores might be clinically important and will need to be explored in future comparative studies.
不可修复的肩袖撕裂(IRCT)的治疗是一项重大挑战,各种治疗选择应运而生。上盂唇重建术(SCR)对于IRCT患者来说是一种很有前景的手术方法。
研究SCR的临床疗效,并比较同种异体移植物和自体移植物。
系统评价;证据等级,4级。
使用PubMed、Cochrane图书馆、Embase、Scopus和谷歌学术数据库搜索相关文章。我们使用医学主题词(MeSH)和自然关键词(上盂唇和(关节囊或盂唇)和重建)。此外,我们使用非随机研究方法学指数(MINORS)筛选高质量文章。我们总结了每项纳入研究的特征数据和常用的疗效指标,并使用Huisstede等人(2013年)提出的基于证据的趋势概念进行描述性分析。
共选择并分析了10篇文章(374例肩部),平均随访27.2个月。其中4篇关于自体移植物的SCR文章,4篇关于同种异体移植物的SCR文章,2篇关于自体移植物和同种异体移植物联合使用的SCR文章。自体移植物和同种异体移植物的前屈(FE)平均增加角度分别为48.7°和33.3°,疼痛视觉模拟量表评分分别改善了3.5和3.3,美国肩肘外科医师(ASES)评分分别增加了47.3和31.9,肩峰下间隙分别增加了1.2和1.8mm。此外,自体移植物和同种异体移植物的移植物撕裂数分别为16例(10.0%)和17例(12.9%),其他并发症数分别为12例(7.5%)和6例(3.9%),再次手术数分别为(3.1%)和14例(8.2%)。
自体移植物和同种异体移植物均改善了临床疗效。虽然自体移植物组和同种异体移植物组的移植物撕裂率似乎相似,但自体移植物组没有转为反向全肩关节置换术的病例。此外,我们发现了3个基于证据的趋势:(1)自体移植物和同种异体移植物均有FE和临床评分显著改善的趋势;(2)自体移植物改善内旋、同种异体移植物改善外展的趋势;(3)自体移植物改善外展、同种异体移植物改善内旋和外旋的微弱趋势。虽然无法对两组进行统计学比较,但ASES评分的差异可能具有临床意义,需要在未来的比较研究中进一步探讨。